Discover Magazine Drugs Behind the Ozempic Weight-Loss Boom May Also Lower the Risk of Addiction
Tracking over 600,000 veterans shows that GLP-1 receptor agonists are linked to lower rates of substance use disorders, fewer overdoses, and fewer addiction-related hospital visits.